Executive Director, Global Program Lead, Oncology (Pumitamig)
Bristol Myers Squibb
5 months ago
Remote friendly (Lawrence, NJ)
United States
Clinical Research and Development
Position Summary
Executive Director, Global Program Leader, Pumitamig. Reports to Vice President, GPL Pumitamig. Leads a portion of the Pumitamig development book of work (PD-L1xVEGFF bispecific antibody in solid tumors with BioNTech collaboration).
Key Responsibilities
- Create asset vision and design/execute development programs supporting R&D portfolio goals.
- Engage cross-company expertise; define/revise/champion development strategies using advisory groups/governance.
- Analyze progress; deliver key data/interpretation for robust, rapid, data-driven decisions.
- Deliver high-quality assets to commercial with competitive profile to address unmet needs and shareholder value.
- Ensure program standards (quality, budget, schedule, compliance); streamline and enable continuous improvements.
- Align program strategy/operational plans with functional capabilities; communicate risks, competitive impacts, and milestone progress.
- Drive portfolio-level strategy for internal/external opportunities.
- Participate in NDA/BLA filings; develop strategy for orphan drug designation.
- Work with Health Authorities/Advisory Committees on clinical trial design and endpoints.
- Lead program strategy and clinical/commercialization plans, business case development; incorporate access/pricing/reimbursement needs into trial design.
- Build external collaborations (KOLs, alliances, patient advocacy, health authorities) and integrate insights.
- Support analysis/interpretation of clinical data; translate into scientific communications and commercial strategy.
Leadership and Matrix Alignment
- Collaborate across matrix; problem-solve and make enterprise decisions.
- Develop and lead a high-performing cross-functional matrix team; hold self/others accountable.
Qualifications & Experience
- MD/PhD/DVM/PharmD/MBA or equivalent advanced degree; drug development experience.
- 10+ years drug development; leadership experience in academic or industry.
- Deep expertise in drug development, matrix leadership, regulatory expectations; oncology experience (lung preferred).
- Knowledge of regulatory expectations and exploratory development functional areas (e.g., CMC, translational, early clinical).
- Track record influencing across complex global organizations; presenting/influencing senior leaders.
- Ability to assess sparse complex data, act under uncertainty, and manage multi-asset priorities.
Benefits (explicitly stated)
- Health Coverage: medical, pharmacy, dental, vision.
- Wellbeing Support (e.g., EAP and wellbeing programs).
- Financial Well-being & Protection (e.g., 401(k), disability, life insurance, etc.).
- Paid time off (flexible time off / vacation and holidays as described).
Compensation (explicitly stated)
$297,590 - $360,603.
Application Instructions
- If you come across a role that intrigues you but doesn’t perfectly line up, encouraged to apply anyway.
Executive Director, Global Program Leader, Pumitamig. Reports to Vice President, GPL Pumitamig. Leads a portion of the Pumitamig development book of work (PD-L1xVEGFF bispecific antibody in solid tumors with BioNTech collaboration).
Key Responsibilities
- Create asset vision and design/execute development programs supporting R&D portfolio goals.
- Engage cross-company expertise; define/revise/champion development strategies using advisory groups/governance.
- Analyze progress; deliver key data/interpretation for robust, rapid, data-driven decisions.
- Deliver high-quality assets to commercial with competitive profile to address unmet needs and shareholder value.
- Ensure program standards (quality, budget, schedule, compliance); streamline and enable continuous improvements.
- Align program strategy/operational plans with functional capabilities; communicate risks, competitive impacts, and milestone progress.
- Drive portfolio-level strategy for internal/external opportunities.
- Participate in NDA/BLA filings; develop strategy for orphan drug designation.
- Work with Health Authorities/Advisory Committees on clinical trial design and endpoints.
- Lead program strategy and clinical/commercialization plans, business case development; incorporate access/pricing/reimbursement needs into trial design.
- Build external collaborations (KOLs, alliances, patient advocacy, health authorities) and integrate insights.
- Support analysis/interpretation of clinical data; translate into scientific communications and commercial strategy.
Leadership and Matrix Alignment
- Collaborate across matrix; problem-solve and make enterprise decisions.
- Develop and lead a high-performing cross-functional matrix team; hold self/others accountable.
Qualifications & Experience
- MD/PhD/DVM/PharmD/MBA or equivalent advanced degree; drug development experience.
- 10+ years drug development; leadership experience in academic or industry.
- Deep expertise in drug development, matrix leadership, regulatory expectations; oncology experience (lung preferred).
- Knowledge of regulatory expectations and exploratory development functional areas (e.g., CMC, translational, early clinical).
- Track record influencing across complex global organizations; presenting/influencing senior leaders.
- Ability to assess sparse complex data, act under uncertainty, and manage multi-asset priorities.
Benefits (explicitly stated)
- Health Coverage: medical, pharmacy, dental, vision.
- Wellbeing Support (e.g., EAP and wellbeing programs).
- Financial Well-being & Protection (e.g., 401(k), disability, life insurance, etc.).
- Paid time off (flexible time off / vacation and holidays as described).
Compensation (explicitly stated)
$297,590 - $360,603.
Application Instructions
- If you come across a role that intrigues you but doesn’t perfectly line up, encouraged to apply anyway.